JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home


*13 !**	Sun, 7/29/2012, 2:00 PM - 3:50 PM	HQ-Sapphire MN
Increasing Clinical Program Success with Modeling and Simulation — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Olga V Marchenko, Quintiles, Inc.
Chair(s): Olga V Marchenko, Quintiles, Inc.
2:05 PM	Improving Clinical Study Design and Understanding via Modeling and Simulation — Chyi-Hung Hsu, Janssen Pharmaceuticals, Inc. ; Jose Carlos Pinheiro, Johnson & Johnson ; Fei Chen, Janssen Pharmaceuticals, Inc.
2:25 PM	Benefits of Model-Based Drug Development: A Rigorous Case Study — Russell Reeve, Quintiles, Inc.
2:45 PM	Utilizing Modeling and Simulation to Optimize Phase 2 for Decisionmaking — Brenda Gaydos, Eli Lilly and Company
3:05 PM	Improving Oncology Clinical Program by Use of Innovative Designs and Comparing via Simulations — Joel Miller, Eli Lilly and Company/ImClone ; Tom Parke, Tessella Inc. ; Donald Berry, MD Anderson Cancer Center ; Olga V Marchenko, Quintiles, Inc. ; Inna Perevozskaya, Pfizer Inc. ; Yanping Wang, Eli Lilly and Company
3:25 PM	Discussant: Martin Kimber, Tessella Inc.
3:45 PM	Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.